BRAMBILLA, GIANMARIA
 Distribuzione geografica
Continente #
NA - Nord America 5.351
AS - Asia 2.168
EU - Europa 1.949
SA - Sud America 341
Continente sconosciuto - Info sul continente non disponibili 122
AF - Africa 61
OC - Oceania 5
Totale 9.997
Nazione #
US - Stati Uniti d'America 4.978
SG - Singapore 831
CN - Cina 444
DE - Germania 341
IT - Italia 337
CA - Canada 312
VN - Vietnam 284
RU - Federazione Russa 274
HK - Hong Kong 264
SE - Svezia 261
BR - Brasile 241
IE - Irlanda 205
UA - Ucraina 164
FR - Francia 111
GB - Regno Unito 106
IN - India 78
BD - Bangladesh 57
FI - Finlandia 53
AR - Argentina 33
KR - Corea 26
TR - Turchia 26
IQ - Iraq 24
BE - Belgio 19
MX - Messico 19
JP - Giappone 17
PL - Polonia 17
CO - Colombia 16
NL - Olanda 16
ZA - Sudafrica 15
ES - Italia 13
PK - Pakistan 13
EC - Ecuador 12
CL - Cile 11
ID - Indonesia 11
PH - Filippine 11
VE - Venezuela 11
SA - Arabia Saudita 9
EG - Egitto 8
PY - Paraguay 8
AE - Emirati Arabi Uniti 7
CZ - Repubblica Ceca 7
IL - Israele 7
MA - Marocco 7
UZ - Uzbekistan 7
ET - Etiopia 6
EU - Europa 6
LB - Libano 6
TH - Thailandia 6
GT - Guatemala 5
JM - Giamaica 5
KE - Kenya 5
KZ - Kazakistan 5
MY - Malesia 5
NI - Nicaragua 5
NP - Nepal 5
PE - Perù 5
AT - Austria 4
AZ - Azerbaigian 4
HN - Honduras 4
IR - Iran 4
JO - Giordania 4
RO - Romania 4
SC - Seychelles 4
SV - El Salvador 4
TT - Trinidad e Tobago 4
AU - Australia 3
BB - Barbados 3
BG - Bulgaria 3
BJ - Benin 3
CH - Svizzera 3
CR - Costa Rica 3
CW - ???statistics.table.value.countryCode.CW??? 3
DZ - Algeria 3
GR - Grecia 3
OM - Oman 3
PA - Panama 3
TN - Tunisia 3
BA - Bosnia-Erzegovina 2
KH - Cambogia 2
LT - Lituania 2
NZ - Nuova Zelanda 2
PR - Porto Rico 2
PS - Palestinian Territory 2
SN - Senegal 2
UY - Uruguay 2
AL - Albania 1
AM - Armenia 1
AO - Angola 1
BO - Bolivia 1
BZ - Belize 1
CG - Congo 1
CI - Costa d'Avorio 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GE - Georgia 1
GP - Guadalupe 1
KG - Kirghizistan 1
KW - Kuwait 1
LU - Lussemburgo 1
LY - Libia 1
Totale 9.878
Città #
Ashburn 535
Singapore 469
Woodbridge 366
Ann Arbor 351
San Jose 285
Fairfield 273
Hong Kong 257
Chandler 256
Houston 256
Frankfurt am Main 217
Toronto 213
Dublin 196
Jacksonville 176
Council Bluffs 162
Seattle 129
New York 126
Dearborn 117
Cambridge 112
Wilmington 108
Milan 106
Santa Clara 81
Hanoi 80
Los Angeles 79
Ho Chi Minh City 78
Princeton 74
Beijing 72
Chicago 68
Nanjing 50
Dallas 43
The Dalles 42
Lauterbourg 37
Rome 35
Lachine 33
Lawrence 32
Altamura 30
Boardman 30
Buffalo 27
Shanghai 26
Seoul 25
São Paulo 25
Moscow 24
Hefei 22
Munich 20
Phoenix 20
Brussels 17
Nanchang 17
Orem 17
Shenyang 16
Tianjin 16
Hebei 15
San Diego 15
Ottawa 14
Atlanta 13
Belo Horizonte 13
Helsinki 13
North Bergen 13
Montreal 12
Tokyo 12
Baghdad 11
Chennai 11
Turin 11
Warsaw 11
Andover 10
Changsha 10
Columbus 10
Düsseldorf 10
Figino 10
Fremont 10
Guangzhou 10
Haiphong 10
London 10
Da Nang 9
Hangzhou 9
Boston 8
Denver 8
Lissone 8
Miami 8
Zhengzhou 8
Las Vegas 7
Newark 7
Ningbo 7
Rio de Janeiro 7
Salt Lake City 7
Turku 7
Addis Ababa 6
Brooklyn 6
Caracas 6
Dhaka 6
Guayaquil 6
Jinan 6
Medellín 6
Mexico City 6
Norwalk 6
Philadelphia 6
Porto Alegre 6
Santiago 6
Stockholm 6
Tampa 6
Cairo 5
Jiaxing 5
Totale 6.294
Nome #
The Pamela study: main findings and perspectives 350
Prevalence of cardiovascular risk factors in an unselected Italian population. Results of the CardioLab Project 2004-2008 337
Regional differences in sympathetic activation in lean and obese normotensive individuals with obstructive sleep apnoea 337
It is never too late for a genetic disease: a case of a 79-year-old man with persistent hypokalemia 336
Comparative effects of nebivolol and metoprolol on red cell distribution width and neutrophil/lymphocyte ratio in patients with newly diagnosed essential hypertension 332
Similarities and differences between renal sympathetic denervation and carotid baroreceptor stimulation 329
Differential effects of enalapril-felodipine versus enalapril-lercanidipine combination drug treatment on sympathetic nerve traffic and metabolic profile in obesity-related hypertension 321
Prognostic Significance of Left Atrial Enlargement in a General Population: Results of the PAMELA Study 321
Role of ambulatory blood pressure monitoring in resistant hypertension 306
Chronic baroreflex activation effects on sympathetic nerve traffic, baroreflex function, and cardiac haemodynamics in heart failure: a proof-of-concept study 303
New-onset left atrial enlargement in a general population 303
Neuroadrenergic disarray in pseudo-resistant and resistant hypertension 295
Structural and functional alterations of subcutaneous small resistance arteries in severe human obesity 292
Blood pressure (clinic, home, 24-h) profiles and clinical correlates in 279
Different neuroadrenergic activation and baroreflex function in resistant and pseudoresistant hypertension: a microneurographic study 276
Clinic, home, 24-hour blood pressure profiles and clinical correlates in resistant hypertension: data from the PAMELA Study 272
Total cardiovascular risk, blood pressure variability and adrenergic overdrive in hypertension: evidence, mechanisms and clinical implications 269
Differential patterns of regional neuroadrenergic cardiovascular drive in acromegalic disease 268
Failure of monolateral renal nerve ablation to exert sympathoinhibitory and blood pressure lowering effects in a patient with resistant hypertension: a case report 264
Blood Pressure Responses to Renal Denervation Precede and Are Independent of the Sympathetic and Baroreflex Effects 261
Sympathetic nerve traffic, insulin resistance and baroreflex control of circulation in patients with resistant hypertension 261
Prognostic value of "partial" and "true" white coat hypertension: data from 16 year follow-up in the PAMELA population 259
Long-term prognistic value of white-coat hypertension: an insight from diagnostic use of both ambulatory and home blood pressure measurements 254
Targets for body fat, blood pressure, lipids, and glucose-lowering interventions in healthy older people 247
Reduced Insulin Sensitivity is Associated with Adrenergic Overdrive Independently on Obesity and Hypertension 240
Marked sympathetic activation and baroreflex dysfunction in true resistant hypertension 235
Novel Antihypertensive Therapies: Renal Sympathetic Nerve Ablation and Carotid Baroreceptor Stimulation 232
Prevalence and clinical characteristics of patients with true resistant hypertension in central and Eastern Europe: data from the BP-CARE study 231
The sympathetic nervous system and new nonpharmacologic approaches to treating hypertension: a focus on renal denervation 227
The role of carotid baroreceptor stimulation 224
Effects of Renal Denervation on Sympathetic Nervous System Activity 223
Sympathetic nerve traffic and blood pressure changes after bilateral renal denervation in resistant hypertension: A time-integrated analysis 219
Reduced insulin sensitivity is associated with adrenergic overdrive in hemochromatosis independently on obesity and hypertension 214
Dissociation between the behaviour of arterial stiffness and muscel sympathetic nerve traffic in patients with htart failure treated with chronic baroreflex activation 187
Prevalence and correlates of new-onset left ventricular geometric abnormalities in a general population 174
Prevalence and main features of resistant hypertension in central and eastern Europe: the BP-CARE Study 174
Metabolic profile and control by treatment and relationships with blood pressure values in patients from central and easter European countries: the BP-CARE metaboli study 174
CPAP in acute pulmonary edema. Our experience of the nurse role in the out of hospital life support 171
Totale 9.997
Categoria #
all - tutte 32.706
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 32.706


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022273 0 0 0 0 35 27 12 25 20 39 38 77
2022/2023882 92 327 70 82 33 144 3 62 54 3 9 3
2023/2024576 12 20 25 46 73 149 130 24 37 4 3 53
2024/20251.235 66 165 59 50 117 18 40 64 171 190 108 187
2025/20263.151 330 126 223 293 403 140 415 124 265 336 275 221
2026/20271.030 57 126 335 431 81 0 0 0 0 0 0 0
Totale 9.997